• Cardio Diagnostics will exhibit at four U.S. benefits conferences in June 2026 to market its cardiovascular risk blood tests and HeartRisk platform.
• First appearances are scheduled for June 4 and June 9 in Philadelphia.
• Additional events are set for June 12 in Countryside, Illinois, and June 25-26 in Chicago.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardio Diagnostics Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260527302873) on May 27, 2026, and is solely responsible for the information contained therein.